{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:35:50Z","timestamp":1773916550223,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T00:00:00Z","timestamp":1406073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s12032-014-0134-1","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T13:58:13Z","timestamp":1406037493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression"],"prefix":"10.1007","volume":"31","author":[{"given":"Yan-ming","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-ling","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-lan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,23]]},"reference":[{"key":"134_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71\u201396.","journal-title":"CA Cancer J Clin"},{"key":"134_CR2","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.3390\/ijms130911705","volume":"13","author":"K Nakayama","year":"2012","unstructured":"Nakayama K, Nakayama N, Katagiri H, Miyazaki K. Mechanisms of ovarian cancer metastasis: biochemical pathways. Int J Mol Sci. 2012;13:11705\u201317.","journal-title":"Int J Mol Sci"},{"key":"134_CR3","first-page":"147","volume":"6","author":"C Sourbier","year":"2012","unstructured":"Sourbier C. Ovarian cancer: emerging molecular-targeted therapies. Biologics. 2012;6:147\u201354.","journal-title":"Biologics"},{"key":"134_CR4","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.2174\/092986712800269362","volume":"19","author":"J Gilabert-Estelles","year":"2012","unstructured":"Gilabert-Estelles J, Braza-Boils A, Ramon LA, Zorio E, Medina P, Espana F, Estelles A. Role of microRNAs in gynecological pathology. Curr Med Chem. 2012;19:2406\u201313.","journal-title":"Curr Med Chem"},{"key":"134_CR5","first-page":"205","volume":"6","author":"A Diaz-Lopez","year":"2014","unstructured":"Diaz-Lopez A, Moreno-Bueno G, Cano A. Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. Cancer Manag Res. 2014;6:205\u201316.","journal-title":"Cancer Manag Res"},{"key":"134_CR6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2174\/138945010790980385","volume":"11","author":"D Gallo","year":"2010","unstructured":"Gallo D, Ferlini C, Scambia G. The epithelial-mesenchymal transition and the estrogen-signaling in ovarian cancer. Curr Drug Targets. 2010;11:474\u201381.","journal-title":"Curr Drug Targets"},{"key":"134_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","volume":"291","author":"D Vergara","year":"2010","unstructured":"Vergara D, Merlot B, Lucot JP, Collinet P, Vinatier D, Fournier I, Salzet M. Epithelial\u2013mesenchymal transition in ovarian cancer. Cancer Lett. 2010;291:59\u201366.","journal-title":"Cancer Lett"},{"key":"134_CR8","doi-asserted-by":"crossref","first-page":"14910","DOI":"10.1074\/jbc.C800074200","volume":"283","author":"M Korpal","year":"2008","unstructured":"Korpal M, Lee ES, Hu G, Kang Y. The miR-200 family inhibits epithelial\u2013mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008;283:14910\u20134.","journal-title":"J Biol Chem"},{"key":"134_CR9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jso.23020","volume":"105","author":"H Kurahara","year":"2012","unstructured":"Kurahara H, Takao S, Maemura K, Mataki Y, Kuwahata T, Maeda K, et al. Epithelial\u2013mesenchymal transition and mesenchymal\u2013epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer. J Surg Oncol. 2012;105:655\u201361.","journal-title":"J Surg Oncol"},{"key":"134_CR10","first-page":"123","volume":"10","author":"H Zheng","year":"2013","unstructured":"Zheng H, Liu JY, Song FJ, Chen KX. Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer. Cancer Biol Med. 2013;10:123\u201330.","journal-title":"Cancer Biol Med"},{"key":"134_CR11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2131","volume":"7","author":"H Peinado","year":"2007","unstructured":"Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7:415\u201328.","journal-title":"Nat Rev Cancer"},{"key":"134_CR12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","volume":"14","author":"J Yang","year":"2008","unstructured":"Yang J, Weinberg RA. Epithelial\u2013mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008;14:818\u201329.","journal-title":"Dev Cell"},{"key":"134_CR13","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1158\/1078-0432.CCR-07-1731","volume":"14","author":"EJ Nam","year":"2008","unstructured":"Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008;14:2690\u20135.","journal-title":"Clin Cancer Res"},{"key":"134_CR14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/embor.2008.74","volume":"9","author":"U Burk","year":"2008","unstructured":"Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008;9:582\u20139.","journal-title":"EMBO Rep"},{"key":"134_CR15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1100\/tsw.2008.115","volume":"8","author":"EL Paterson","year":"2008","unstructured":"Paterson EL, Kolesnikoff N, Gregory PA, Bert AG, Khew-Goodall Y, Goodall GJ. The microRNA-200 family regulates epithelial to mesenchymal transition. Sci World J. 2008;8:901\u20134.","journal-title":"Sci World J"},{"key":"134_CR16","first-page":"414","volume":"2","author":"CR Schoof","year":"2012","unstructured":"Schoof CR, Botelho EL, Izzotti A, dos Reis Vasques L. MicroRNAs in cancer treatment and prognosis. Am J Cancer Res. 2012;2:414\u201333.","journal-title":"Am J Cancer Res"},{"key":"134_CR17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1515\/cclm-2011-0847","volume":"50","author":"JD Kuhlmann","year":"2012","unstructured":"Kuhlmann JD, Rasch J, Wimberger P, Kasimir-Bauer S. microRNA and the pathogenesis of ovarian cancer\u2014a new horizon for molecular diagnostics and treatment? Clin Chem Lab Med. 2012;50:601\u201315.","journal-title":"Clin Chem Lab Med"},{"key":"134_CR18","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/2159-8290.CD-13-0159","volume":"3","author":"M Nishimura","year":"2013","unstructured":"Nishimura M, Jung EJ, Shah MY, Lu C, Spizzo R, Shimizu M, et al. Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment. Cancer Discov. 2013;3:1302\u201315.","journal-title":"Cancer Discov"},{"key":"134_CR19","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.biocel.2010.01.014","volume":"42","author":"MT Jaarsveld van","year":"2010","unstructured":"van Jaarsveld MT, Helleman J, Berns EM, Wiemer EA. MicroRNAs in ovarian cancer biology and therapy resistance. Int J Biochem Cell Biol. 2010;42:1282\u201390.","journal-title":"Int J Biochem Cell Biol"},{"key":"134_CR20","first-page":"612","volume":"32","author":"Lin-xia Li S-dL","year":"2011","unstructured":"S-dL Lin-xia Li, Yang Yi-xia, Wan Xiao-ping. Changes of miR-200c expression in ovarian cancer and its clinical significance. Acad J Sec Mil Med Univ. 2011;32:612\u20136.","journal-title":"Acad J Sec Mil Med Univ"},{"key":"134_CR21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2009.08.009","volume":"116","author":"A Bendoraite","year":"2010","unstructured":"Bendoraite A, Knouf EC, Garg KS, Parkin RK, Kroh EM, O\u2019Briant KC, et al. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecol Oncol. 2010;116:117\u201325.","journal-title":"Gynecol Oncol"},{"key":"134_CR22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2009.05.022","volume":"114","author":"X Hu","year":"2009","unstructured":"Hu X, Macdonald DM, Huettner PC, Feng Z, El Naqa IM, Schwarz JK, et al. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. Gynecol Oncol. 2009;114:457\u201364.","journal-title":"Gynecol Oncol"},{"key":"134_CR23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10911-012-9244-6","volume":"17","author":"EN Howe","year":"2012","unstructured":"Howe EN, Cochrane DR, Richer JK. The miR-200 and miR-221\/222 microRNA families: opposing effects on epithelial identity. J Mammary Gland Biol Neoplasia. 2012;17:65\u201377.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"134_CR24","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","volume":"10","author":"PA Gregory","year":"2008","unstructured":"Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10:593\u2013601.","journal-title":"Nat Cell Biol"},{"key":"134_CR25","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1101\/gad.1640608","volume":"22","author":"SM Park","year":"2008","unstructured":"Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008;22:894\u2013907.","journal-title":"Genes Dev"},{"key":"134_CR26","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/embor.2010.117","volume":"11","author":"S Brabletz","year":"2010","unstructured":"Brabletz S, Brabletz T. The ZEB\/miR-200 feedback loop\u2014a motor of cellular plasticity in development and cancer? EMBO Rep. 2010;11:670\u20137.","journal-title":"EMBO Rep"},{"key":"134_CR27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4161\/cbt.10.3.12548","volume":"10","author":"PS Mongroo","year":"2010","unstructured":"Mongroo PS, Rustgi AK. The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol Ther. 2010;10:219\u201322.","journal-title":"Cancer Biol Ther"},{"key":"134_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10911-012-9241-9","volume":"17","author":"S Valastyan","year":"2012","unstructured":"Valastyan S. Roles of microRNAs and other non-coding RNAs in breast cancer metastasis. J Mammary Gland Biol Neoplasia. 2012;17:23\u201332.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"134_CR29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.lungcan.2013.11.024","volume":"83","author":"CS Ho","year":"2014","unstructured":"Ho CS, Yap SH, Phuah NH, In LL, Hasima N. MicroRNAs associated with tumour migration, invasion and angiogenic properties in A549 and SK-Lu1 human lung adenocarcinoma cells. Lung Cancer. 2014;83:154\u201362.","journal-title":"Lung Cancer"},{"key":"134_CR30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-62703-547-7_14","volume":"1049","author":"MV Iorio","year":"2013","unstructured":"Iorio MV, Croce CM. MicroRNA profiling in ovarian cancer. Methods Mol Biol. 2013;1049:187\u201397.","journal-title":"Methods Mol Biol"},{"key":"134_CR31","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00018-012-0935-3","volume":"69","author":"A Gheldof","year":"2012","unstructured":"Gheldof A, Hulpiau P, van Roy F, De Craene B, Berx G. Evolutionary functional analysis and molecular regulation of the ZEB transcription factors. Cell Mol Life Sci. 2012;69:2527\u201341.","journal-title":"Cell Mol Life Sci"},{"key":"134_CR32","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1158\/0008-5472.CAN-07-1058","volume":"67","author":"GJ Hurteau","year":"2007","unstructured":"Hurteau GJ, Carlson JA, Spivack SD, Brock GJ. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 2007;67:7972\u20136.","journal-title":"Cancer Res"},{"key":"134_CR33","doi-asserted-by":"crossref","first-page":"7846","DOI":"10.1158\/0008-5472.CAN-08-1942","volume":"68","author":"CP Bracken","year":"2008","unstructured":"Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial\u2013mesenchymal transition. Cancer Res. 2008;68:7846\u201354.","journal-title":"Cancer Res"},{"key":"134_CR34","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1007\/s13277-013-0928-3","volume":"34","author":"X Yu","year":"2013","unstructured":"Yu X, Zhang X, Bi T, Ding Y, Zhao J, Wang C, et al. MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma. Tumour Biol. 2013;34:3501\u20138.","journal-title":"Tumour Biol"},{"key":"134_CR35","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s12032-011-0117-4","volume":"29","author":"J Chen","year":"2012","unstructured":"Chen J, Tian W, Cai H, He H, Deng Y. Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer. Med Oncol. 2012;29:2527\u201334.","journal-title":"Med Oncol"},{"key":"134_CR36","doi-asserted-by":"crossref","first-page":"e50469","DOI":"10.1371\/journal.pone.0050469","volume":"7","author":"F Kopp","year":"2012","unstructured":"Kopp F, Oak PS, Wagner E, Roidl A. miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression. PLoS One. 2012;7:e50469.","journal-title":"PLoS One"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0134-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-014-0134-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0134-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T02:30:07Z","timestamp":1565663407000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-014-0134-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,23]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["134"],"URL":"https:\/\/doi.org\/10.1007\/s12032-014-0134-1","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,23]]},"article-number":"134"}}